Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY
-
Founded in:
1994-05-19 -
Country:
China -
Address:
No. 388, Hahei Highway, Hulan District (production base No. 109, Xuefu Road, Nangang District, No. 1, Junmin Street, Xiangfang District) -
Tax NO.:
912301008280277137 -
Registered Funds:
- -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ceftizoxime sodium |
It is a third-generation cephalosporin antibiotic with strong activity against Enterobacteriaceae, and has a strong antibacterial effect on Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, etc. It has a strong antibacterial effect on Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis, and also has a good effect on hemolytic streptococci and pneumococci; the MIC for Staphylococcus aureus is 2-4 mg/L, methicillin-resistant Staphylococci and enterococci are resistant to this product, and most Bacteroides fragilis are resistant to this product.
More
It is a third-generation cephalosporin antibiotic with strong activity against Enterobacteriaceae, and has a strong antibacterial effect on Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, etc. It has a strong antibacterial effect on Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis, and also has a good effect on hemolytic streptococci and pneumococci; the MIC for Staphylococcus aureus is 2-4 mg/L, methicillin-resistant Staphylococci and enterococci are resistant to this product, and most Bacteroides fragilis are resistant to this product. |
68401-82-1 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amoxicillin sodium |
It works by inhibiting the biosynthesis of cell wall mucopolypeptides and is effective against Gram-positive aerobic microorganisms (such as faecal streptococci, Staphylococci, Streptococcus pneumoniae, Streptococci) and some Gram-negative aerobic microorganisms.
More
It works by inhibiting the biosynthesis of cell wall mucopolypeptides and is effective against Gram-positive aerobic microorganisms (such as faecal streptococci, Staphylococci, Streptococcus pneumoniae, Streptococci) and some Gram-negative aerobic microorganisms. |
34642-77-8 | 16 | |
| Sulbactam sodium |
It can inhibit the beta-lactamase produced by most bacteria and restore the sensitivity of bacteria to amoxicillin.
More
It can inhibit the beta-lactamase produced by most bacteria and restore the sensitivity of bacteria to amoxicillin. |
69388-84-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amoxicillin sodium |
It is a bactericidal broad-spectrum antibiotic. When used in combination with sulbactam sodium, it can be protected from destruction by β-lactamase and has a bactericidal effect on a variety of Gram-positive and Gram-negative bacteria.
More
It is a bactericidal broad-spectrum antibiotic. When used in combination with sulbactam sodium, it can be protected from destruction by β-lactamase and has a bactericidal effect on a variety of Gram-positive and Gram-negative bacteria. |
34642-77-8 | 16 | |
| Sulbactam sodium |
Irreversible broad-spectrum β-lactamase inhibitor that protects amoxicillin from destruction by β-lactamases and enhances its effectiveness against enzyme-producing resistant bacteria.
More
Irreversible broad-spectrum β-lactamase inhibitor that protects amoxicillin from destruction by β-lactamases and enhances its effectiveness against enzyme-producing resistant bacteria. |
69388-84-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amoxicillin sodium |
Amoxicillin is a bactericidal broad-spectrum antibiotic. Due to the presence of sulbactam sodium, amoxicillin can be protected from the destruction of β-lactamase, thus making it sensitive to bacteria that are resistant to amoxicillin and produce β-lactamase. This product is a bactericidal antibiotic that can kill a variety of Gram-positive and Gram-negative bacteria in clinical practice.
More
Amoxicillin is a bactericidal broad-spectrum antibiotic. Due to the presence of sulbactam sodium, amoxicillin can be protected from the destruction of β-lactamase, thus making it sensitive to bacteria that are resistant to amoxicillin and produce β-lactamase. This product is a bactericidal antibiotic that can kill a variety of Gram-positive and Gram-negative bacteria in clinical practice. |
34642-77-8 | 16 | |
| Sulbactam sodium |
Sulbactam sodium is an irreversible broad-spectrum β-lactamase, which can make amoxicillin lose its antibacterial activity. By inhibiting β-lactamase, sulbactam sodium protects amoxicillin from being destroyed and enhances its antibacterial effect, especially against drug-resistant bacteria that produce β-lactamase.
More
Sulbactam sodium is an irreversible broad-spectrum β-lactamase, which can make amoxicillin lose its antibacterial activity. By inhibiting β-lactamase, sulbactam sodium protects amoxicillin from being destroyed and enhances its antibacterial effect, especially against drug-resistant bacteria that produce β-lactamase. |
69388-84-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
This product is an acetanilide antipyretic analgesic. It inhibits the prostaglandin synthase in the hypothalamic temperature regulation center, reduces the synthesis and release of prostaglandin PGE1, causes peripheral vasodilation and sweating, and achieves an antipyretic effect. Its antipyretic effect is similar to that of aspirin; it inhibits the synthesis and release of prostaglandin PGE1, bradykinin and histamine, increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
This product is an acetanilide antipyretic analgesic. It inhibits the prostaglandin synthase in the hypothalamic temperature regulation center, reduces the synthesis and release of prostaglandin PGE1, causes peripheral vasodilation and sweating, and achieves an antipyretic effect. Its antipyretic effect is similar to that of aspirin; it inhibits the synthesis and release of prostaglandin PGE1, bradykinin and histamine, increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
103-90-2 | 68 |